Audacious acquires cannabinoid infused shot beverage brand LOOS

TAGS

Australis Capital (doing business as Audacious) has acquired California-based cannabinoid infused shot beverage company Gary Maverick, which operates under the brand name LOOS.

The financial terms of the deal were not disclosed.

Audacious said that with LOOS it is adding an exciting new beverage brand and product range to its portfolio, which is targeted at a generally cannabis savvy and influential target market.

According to Audacious, Loos’ management team has more than a decade of collective experience in cannabis with brands like 710 Labs, Plus Products, Flow Kana, and Loudpack. Their first product – a 2oz drink (shot) infused with 100mg of THC, is available in Orange Crush Sativa, Lavender Indica, and Green Dream Hybrid, flavors.

See also  AstraZeneca's Alexion to boost rare disease commitment with Pfizer's gene therapy programs

All the three flavors are said to have a unique terpene profile and are infused with added nutraceuticals for enhanced functionality.

Anthony Bendana and Ben Koppel – LOOS founders jointly said: “As two people who worked their way up from the bottom in this industry, we saw an opportunity to create a brand with quality, effective, and affordable products that specifically caters to the cannabis community we love.

“The CPG space is filled with brands focusing on new consumers and the canna-curious and we’re excited to join them on the shelves and counters to help the entire cannabis community get Loos. We believe this industry should aspire to the highest ideals of the cannabis pioneers that powered it into existence and want Loos to be an ambassador for the type of radical empathy, compassion, and community we could all use to help us stay loose.”

Audacious acquires cannabinoid infused shot beverage brand LOOS

Audacious acquires cannabinoid infused shot beverage brand LOOS. (Photo courtesy of CNW Group/Australis Capital Inc.)

Loos’ cannabinoid infused shot beverage products are based on a nano-emulsion technology platform for quick onset. They are all natural, vegan, free from gluten and contain low sugar and also low calories.

See also  Marksans Pharma bags FDA approval for Mucinex bioequivalent tablets

After foraying into the market in the 2oz drink category, Loos intends to release various other products across several key categories, which include CBD infused shots.

Terry Booth – CEO of Audacious said: “Launching a logistics-light SKU into the beverage market, I have always believed, will make all the difference in accelerating sales in this category. Furthermore, this transaction also signals our intended entry into the CBD infused drinks market, which industry insiders anticipate may become one of the most important product categories in our industry.

See also  Aurobindo subsidiary Eugia gets FDA approval for Cyclophosphamide Injection

“Acquiring LOOS and the team behind the brand gives us a head start and adds another product and revenue generating line to our portfolio. as well as sees Audacious increasing our presence in California.”

CATEGORIES
TAGS
Share This